Matches in Nanopublications for { ?s ?p "Treatment of human peripheral blood mononuclear cells (PBMCs) with dexamethasone (100 nM) or BAY11-7082 (1 μM) resulted in inhibition of spike glycoprotein S1-induced NF-κB activation." ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- SENTENCE label "Treatment of human peripheral blood mononuclear cells (PBMCs) with dexamethasone (100 nM) or BAY11-7082 (1 μM) resulted in inhibition of spike glycoprotein S1-induced NF-κB activation." provenance.
- SENTENCE label "Treatment of human peripheral blood mononuclear cells (PBMCs) with dexamethasone (100 nM) or BAY11-7082 (1 μM) resulted in inhibition of spike glycoprotein S1-induced NF-κB activation." provenance.
- SENTENCE label "Treatment of human peripheral blood mononuclear cells (PBMCs) with dexamethasone (100 nM) or BAY11-7082 (1 μM) resulted in inhibition of spike glycoprotein S1-induced NF-κB activation." provenance.
- SENTENCE label "Treatment of human peripheral blood mononuclear cells (PBMCs) with dexamethasone (100 nM) or BAY11-7082 (1 μM) resulted in inhibition of spike glycoprotein S1-induced NF-κB activation." provenance.
- SENTENCE label "Treatment of human peripheral blood mononuclear cells (PBMCs) with dexamethasone (100 nM) or BAY11-7082 (1 μM) resulted in inhibition of spike glycoprotein S1-induced NF-κB activation." provenance.
- SENTENCE label "Treatment of human peripheral blood mononuclear cells (PBMCs) with dexamethasone (100 nM) or BAY11-7082 (1 μM) resulted in inhibition of spike glycoprotein S1-induced NF-κB activation." provenance.
- SENTENCE label "Treatment of human peripheral blood mononuclear cells (PBMCs) with dexamethasone (100 nM) or BAY11-7082 (1 μM) resulted in inhibition of spike glycoprotein S1-induced NF-κB activation." provenance.
- SENTENCE label "Treatment of human peripheral blood mononuclear cells (PBMCs) with dexamethasone (100 nM) or BAY11-7082 (1 μM) resulted in inhibition of spike glycoprotein S1-induced NF-κB activation." provenance.
- SENTENCE label "Treatment of human peripheral blood mononuclear cells (PBMCs) with dexamethasone (100 nM) or BAY11-7082 (1 μM) resulted in inhibition of spike glycoprotein S1-induced NF-κB activation." provenance.